Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06294652
Status:
RECRUITING
Last Update Posted:
2024-03-05
First Post:
2024-02-28
Brief Title:
AGMT Austrian Lymphoma Registry
Sponsor:
Organization:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
10 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
The Lymphoma registry will be accompanied by an optional biobanking program Sample collection will be limited to patients that have signed an additional biobanking IC
The samples are taken as part of the clinical routine
Enrollment Count:
4000
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Other |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 104523 |
Who Masked List: